{{Rsnum
|rsid = 9317284
|Orientation=plus
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Chromosome=13
|position=63060217
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 78.5 | 21.5 | 0.0
| HCB | 84.4 | 15.6 | 0.0
| JPT | 86.4 | 11.4 | 2.3
| YRI | 100.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 84.4 | 15.6 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs9317284
|PubMedID=17903296
|Condition=Bone mineral density
|Gene=Intergenic
|Risk Allele=
|pValue=2.00E-007
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs9317284
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:17903296; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association with bone mass and geometry in the Framingham Heart Study (Initial Sample Size: 1,141 individuals (Framingham); Replication Sample Size: NR). This variant is associated with Bone mineral density.
|Drugs=
|Drug Classes=
|Diseases=Bone Diseases; Bone Diseases, Metabolic; Fractures, Bone
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356523
}}

{{PMID Auto
|PMID=19629617
|Title=Replication study of candidate genes/loci associated with osteoporosis based on genome-wide screening.
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs9317284
|overall_frequency_n=30
|overall_frequency_d=60
|overall_frequency=0.5
|n_genomes=26
|n_genomes_annotated=0
|n_haplomes=26
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}